Literature DB >> 2003983

Malignant disease in the mothers of a population-based series of young adults with bone and soft tissue sarcomas.

A L Hartley1, J M Birch, V Blair.   

Abstract

Mothers of a population-based series of young adults with bone and soft tissue sarcoma were traced and their cancer risks estimated. No overall excess of cancers compared with expected numbers calculated from population rates was seen but mothers of patients with synovial sarcoma had significantly more cancers than expected and this was accounted for mainly by an excess of breast cancer. In addition there were strong indications that a proportion of cases were members of families with inherited cancer-prone syndromes, in particular with neurofibromatosis or with the Li Fraumeni cancer family syndrome.

Entities:  

Mesh:

Year:  1991        PMID: 2003983      PMCID: PMC1971866          DOI: 10.1038/bjc.1991.96

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Cancer in the families of children with soft tissue sarcoma.

Authors:  J M Birch; A L Hartley; V Blair; A M Kelsey; M Harris; M D Teare; P H Jones
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

2.  Neurofibromatosis in children with soft tissue sarcoma.

Authors:  A L Hartley; J M Birch; H B Marsden; M Harris; V Blair
Journal:  Pediatr Hematol Oncol       Date:  1988       Impact factor: 1.969

3.  Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience.

Authors:  C A Presant; W O Russell; R W Alexander; Y S Fu
Journal:  J Clin Oncol       Date:  1986-11       Impact factor: 44.544

4.  A cancer family syndrome in twenty-four kindreds.

Authors:  F P Li; J F Fraumeni; J J Mulvihill; W A Blattner; M G Dreyfus; M A Tucker; R W Miller
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

5.  Breast cancer risk in mothers of children with osteosarcoma and chondrosarcoma.

Authors:  A L Hartley; J M Birch; H B Marsden; M Harris
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

  5 in total
  3 in total

1.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

2.  Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Authors:  He Li; Saumya D Sisoudiya; Bailey A Martin-Giacalone; Michael M Khayat; Shannon Dugan-Perez; Deborah A Marquez-Do; Michael E Scheurer; Donna Muzny; Eric Boerwinkle; Richard A Gibbs; Yueh-Yun Chi; Donald A Barkauskas; Tammy Lo; David Hall; Douglas R Stewart; Joshua D Schiffman; Stephen X Skapek; Douglas S Hawkins; Sharon E Plon; Aniko Sabo; Philip J Lupo
Journal:  J Natl Cancer Inst       Date:  2021-07-01       Impact factor: 13.506

3.  Next generation sequencing in synovial sarcoma reveals novel gene mutations.

Authors:  Myrella Vlenterie; Melissa H S Hillebrandt-Roeffen; Uta E Flucke; Patricia J T A Groenen; Bastiaan B J Tops; Eveline J Kamping; Rolph Pfundt; Diederik R H de Bruijn; Ad H M Geurts van Kessel; Han J H J M van Krieken; Winette T A van der Graaf; Yvonne M H Versleijen-Jonkers
Journal:  Oncotarget       Date:  2015-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.